Literature DB >> 21731535

Methamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug.

Jean Lud Cadet1, Christie Brannock, Bruce Ladenheim, Michael T McCoy, Genevieve Beauvais, Amber B Hodges, Elin Lehrmann, William H Wood, Kevin G Becker, Irina N Krasnova.   

Abstract

Methamphetamine (METH) is a toxic drug of abuse, which can cause significant decreases in the levels of monoamines in various brain regions. However, animals treated with progressively increasing doses of METH over several weeks are protected against the toxic effects of the drug. In the present study, we tested the possibility that this pattern of METH injections might be associated with transcriptional changes in the rat striatum, an area of the brain which is known to be very sensitive to METH toxicity and which is protected by METH preconditioning. We found that the presence and absence of preconditioning followed by injection of large doses of METH caused differential expression in different sets of striatal genes. Quantitative PCR confirmed METH-induced changes in some genes of interest. These include small heat shock 27 kD proteins 1 and 2 (HspB1 and HspB2), brain derived neurotrophic factor (BDNF), and heme oxygenase-1 (Hmox-1). Our observations are consistent with previous studies which have reported that ischemic or pharmacological preconditioning can cause reprogramming of gene expression after lethal ischemic insults. These studies add to the growing literature on the effects of preconditioning on the brain transcriptome.

Entities:  

Keywords:  BDNF; heat shock proteins; methamphetamine; preconditioning; striatum

Year:  2010        PMID: 21731535      PMCID: PMC3118766          DOI: 10.2203/dose-response.10-011.Cadet

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  60 in total

1.  Cognitive performance of current methamphetamine and cocaine abusers.

Authors:  Sara L Simon; Catherine P Domier; Tiffanie Sim; Kimberly Richardson; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

2.  Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6.

Authors:  B Ladenheim; I N Krasnova; X Deng; J M Oyler; A Polettini; T H Moran; M A Huestis; J L Cadet
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

Review 3.  Major physical and psychological harms of methamphetamine use.

Authors:  Shane Darke; Sharlene Kaye; Rebecca McKetin; Johan Duflou
Journal:  Drug Alcohol Rev       Date:  2008-05

4.  Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity.

Authors:  X Deng; B Ladenheim; L I Tsao; J L Cadet
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

5.  Persistence of tolerance to methamphetamine-induced monoamine deficits.

Authors:  Jonathan P Danaceau; Cassandra E Deering; Jayme E Day; Stacy J Smeal; Kamisha L Johnson-Davis; Annette E Fleckenstein; Diana G Wilkins
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

6.  Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model.

Authors:  Lisa E Morrison; Ross J Whittaker; Robert E Klepper; Eric F Wawrousek; Christopher C Glembotski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-30       Impact factor: 4.733

7.  Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation.

Authors:  Oliver H Voss; Sanjay Batra; Sunny J Kolattukudy; M Elba Gonzalez-Mejia; Jeffrey B Smith; Andrea I Doseff
Journal:  J Biol Chem       Date:  2007-06-27       Impact factor: 5.157

8.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

Review 9.  Molecular physiology of preconditioning-induced brain tolerance to ischemia.

Authors:  Tihomir Paul Obrenovitch
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

10.  Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis.

Authors:  Vinay K Dhodda; Kurt A Sailor; Kellie K Bowen; Raghu Vemuganti
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

View more
  14 in total

1.  Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Int J Neuropsychopharmacol       Date:  2014-03-20       Impact factor: 5.176

2.  Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice.

Authors:  B Butler; J Gamble-George; P Prins; A North; J T Clarke; H Khoshbouei
Journal:  J Addict Prev       Date:  2014

3.  Effect of three different regimens of repeated methamphetamine on rats' cognitive performance.

Authors:  Seyedeh Masoumeh Seyedhosseini Tamijani; Elmira Beirami; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Cogn Process       Date:  2017-09-25

4.  Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Authors:  Michael F Salvatore; Vicki A Nejtek; Habibeh Khoshbouei
Journal:  Neurotoxicology       Date:  2018-05-18       Impact factor: 4.294

5.  Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit.

Authors:  Ashley North; Jarod Swant; Michael F Salvatore; Joyonna Gamble-George; Petra Prins; Brittany Butler; Mukul K Mittal; Rebecca Heltsley; John T Clark; Habibeh Khoshbouei
Journal:  Synapse       Date:  2013-02-08       Impact factor: 2.562

6.  Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.

Authors:  Melanie M Hoefer; Ana B Sanchez; Ricky Maung; Cyrus M de Rozieres; Irene C Catalan; Cari C Dowling; Victoria E Thaney; Juan Piña-Crespo; Dongxian Zhang; Amanda J Roberts; Marcus Kaul
Journal:  Exp Neurol       Date:  2014-09-20       Impact factor: 5.330

7.  Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens.

Authors:  Tracey A Martin; Subramaniam Jayanthi; Michael T McCoy; Christie Brannock; Bruce Ladenheim; Tiffany Garrett; Elin Lehrmann; Kevin G Becker; Jean Lud Cadet
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

8.  Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMζ), dopamine, and glutamate receptors.

Authors:  Stephen H Braren; Damian Drapala; Ingrid K Tulloch; Peter A Serrano
Journal:  Front Behav Neurosci       Date:  2014-12-18       Impact factor: 3.558

9.  Electroacupuncture stimulation of the brachial plexus trunk on the healthy side promotes brain-derived neurotrophic factor mRNA expression in the ischemic cerebral cortex of a rat model of cerebral ischemia/reperfusion injury.

Authors:  Zongjun Guo; Lumin Wang
Journal:  Neural Regen Res       Date:  2012-07-25       Impact factor: 5.135

10.  Profiling transcriptomes of human SH-SY5Y neuroblastoma cells exposed to maleic acid.

Authors:  Chia-Chi Wang; Yin-Chi Lin; Yin-Hua Cheng; Chun-Wei Tung
Journal:  PeerJ       Date:  2017-04-05       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.